Tuesday, May 12, 2015 5:26:12 PM
Phytofare might not be a pharmaceutical product, but nevertheless shareholder and of course the health product market and drugstrores have the right to know WHAT it is definitive but just a biodegradable nutraceutical product with some unready analysises, tests here and there and unknown and unpublished half-ready studies (read the news releases and listen carefully to the latest video). As long as those details are not published Phytofare can not be taken seriously - and this is how experts sees this and not just a number of hopeful pennytsock shareholder.
As I said, I appreciate your opinion and I hope by myself for a success, but I still do not feel able to take Plandai as a totally serious company. For me it is still a pennyplay which releases - as most pennyplays do - wonderful news included tons of missing details and proves.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM